Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A look at hepatitis C treatment and pregnancy-related issues.
The U.S. Preventive Services Task Force has reaffirmed its 2009 recommendation.
Researchers analyzed the immunological mechanisms that may drive this difference.
Preterm delivery is defined as giving birth before 37 weeks of gestation.
Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.
At one hospital in Pittsburgh, the rate of pregnant women with hepatitis C seen for delivery rose 60 percent in eight years.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Hepatitis C virus infection is on the rise among women giving birth, putting a new generation at risk for infection.
Hepatitis C virus (HCV) may compromise women’s reproductive capacity. Earlier treatment of the virus may help mitigate such related risks.
Wisconsin and other states have seen a near doubling of women who test positive for hepatitis C during pregnancy.
Unfortunately, no hepatitis C treatment is approved for use among expectant mothers.
A recent study found that hep C was also associated with an increased risk of miscarriage.
The opioid epidemic is likely fueling the rise, which is particularly steep in Appalachia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.